These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33835966)

  • 1. Diagnostic Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Characterization of Intraductal Papillary Mucinous Neoplasms: An Updated Systematic Review and Meta-analysis.
    Kim K; Kim SJ
    Pancreas; 2021 Mar; 50(3):353-361. PubMed ID: 33835966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis.
    Son GM; Kim SJ
    Abdom Radiol (NY); 2019 Feb; 44(2):456-463. PubMed ID: 30132094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic test accuracy of
    Seol HY; Kim YS; Kim SJ
    Clin Radiol; 2021 Nov; 76(11):863.e19-863.e25. PubMed ID: 34261597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of
    Kim SJ; Lee SW; Pak K; Kim IJ; Kim K
    Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
    Seol HY; Kim YS; Kim SJ
    Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis.
    Kim SJ; Lee JS
    World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
    Seol HY; Kim YS; Kim SJ
    Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
    Kim K; Kim SJ
    Leuk Res; 2020 Dec; 99():106475. PubMed ID: 33189988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
    Kim K; Kim SJ
    Clin Imaging; 2021 Nov; 79():251-258. PubMed ID: 34157501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).
    Ohta K; Tanada M; Sugawara Y; Teramoto N; Iguchi H
    Pancreatology; 2017; 17(6):911-919. PubMed ID: 29033011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of
    Ko WS; Kim SJ
    Hell J Nucl Med; 2023; 26(2):132-139. PubMed ID: 37527049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic test accuracies of F-18 FDG PET for characterisation of cardiac masses compared to conventional imaging techniques: systematic review and meta-analysis.
    Kim K; Ko WS; Kim SJ
    Br J Radiol; 2022 Jul; 95(1135):20210263. PubMed ID: 35612548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature.
    Bertagna F; Treglia G; Baiocchi GL; Giubbini R
    Jpn J Radiol; 2013 Apr; 31(4):229-36. PubMed ID: 23315020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of 18 F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer.
    Ko WS; Kim SJ
    Clin Nucl Med; 2023 Jul; 48(7):574-580. PubMed ID: 36976654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed.
    Baiocchi GL; Bertagna F; Gheza F; Grazioli L; Calanducci D; Giubbini R; Portolani N; Giulini SM
    Ann Surg Oncol; 2012 Oct; 19(11):3574-80. PubMed ID: 22752369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of
    Kim SJ; Lee SW; Jeong SY; Pak K; Kim K
    J Vasc Surg; 2019 Jul; 70(1):307-313. PubMed ID: 30922755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.